Congenital Hemolytic AnemiaSymptoms, Doctors, Treatments, Advances & More
Learn About Congenital Hemolytic Anemia
View Main Condition: Anemia
Jefferson Hematology - Honickman Center
Sophie Lanzkron is a Hematologist practicing medicine in Philadelphia, Pennsylvania. Dr. Lanzkron is rated as an Elite provider by MediFind in the treatment of Congenital Hemolytic Anemia. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia. Dr. Lanzkron is board certified in Hematology. Dr. Lanzkron is currently accepting new patients.
Duke Adult Comprehensive Sickle Cell Center - Clinic 2N
Marilyn Telen is a Hematologist practicing medicine in Durham, North Carolina. She has been practicing medicine for over 53 years. Dr. Telen is rated as an Elite provider by MediFind in the treatment of Congenital Hemolytic Anemia. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia. Dr. Telen is board certified in American Board Of Internal Med, Hematology/Oncology and American Board Of Internal Med, Internal Medicine.
Northwell Health Pediatric Hematology/Oncology & Stem Cell Transplant
Banu Aygun is a Pediatric Hematologist Oncology provider practicing medicine in New Hyde Park, New York. Dr. Aygun is rated as an Elite provider by MediFind in the treatment of Congenital Hemolytic Anemia. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, Hemoglobinopathy, and Splenectomy.
Summary: This study is not a treatment protocol and no experimental treatments are involved. Study participants may be seen as needed for clinical, translational and basic research studies, or as medically indicated. Subjects will receive their general medical care outside the NIH and will be seen at our clinic or at CNHS with varying frequency. Subjects may be seen for multiple visits. Subjects may be ask...
Summary: This is a non-ablative (partial) stem cell transplant for patients with severe sickle cell disease or beta-thalassemia requiring red cell transfusions. The intensity of the transplant is slightly increased from our previous transplant regimens. The goal is to aim for higher percentage of donor cells to stably remain in the recipients long term.